rs1378577 — ABCG1 ABCG1 ischemic stroke variant

ABCG1 rs1378577 — An Upstream Regulator of Plaque Stability and Ischemic Stroke Risk

When a macrophage migrates into a lipid-laden arterial wall and begins absorbing oxidized cholesterol, it faces a critical choice: offload that cargo to HDL particles and survive, or become overwhelmed by cholesterol accumulation and transform into a foam cell. This offloading depends heavily on the ABCG1 transporter¹¹ ABCG1 transporter
ATP-binding cassette subfamily G member 1, a membrane pump that mediates cholesterol and phospholipid efflux from macrophages to mature HDL particles — the rate-limiting step in macrophage reverse cholesterol transport. When macrophage ABCG1 function is compromised, cholesterol accumulates, foam cells form, and the necrotic core of atherosclerotic plaques expands — a process that is directly linked to plaque instability and rupture, the proximate cause of most atherothrombotic strokes.

The rs1378577 variant sits approximately 2 kilobases upstream of the ABCG1 transcription start site on chromosome 21. Located in a regulatory region that influences ABCG1 expression, this T>G substitution is part of the promoter-region haplotype that has been studied in relation to ischemic stroke in Asian populations. The G allele at rs1378577 appears to be associated with reduced stroke risk — particularly the atherothrombotic subtype, which is characterized by large-artery atherosclerosis and plaque-related events.

The Mechanism

As an upstream regulatory variant, rs1378577 likely influences the binding of transcriptional regulators to the ABCG1 locus, modulating expression levels rather than altering the protein sequence directly. The ABCG1 gene on chromosome 21 is expressed widely, with particularly important roles in macrophages and monocytes that reside within arterial walls.

ABCG1 facilitates the transfer of cholesterol from macrophage plasma membranes to mature, spherical HDL particles²² ABCG1 facilitates the transfer of cholesterol from macrophage plasma membranes to mature, spherical HDL particles
this step follows ABCA1-mediated lipidation of apolipoprotein A-I into nascent HDL; the two transporters work sequentially — ABCA1 initiates the HDL particle, ABCG1 enlarges it. Reduced ABCG1 expression impairs this efflux step, leaving macrophages with excess intracellular cholesterol that promotes foam cell differentiation. ABCG1 deficiency also amplifies Toll-like receptor (TLR4) signaling in macrophages, heightening inflammatory cytokine release — a mechanism that independently accelerates plaque vulnerability independent of cholesterol level effects.

Variants in the ABCG1 promoter region that reduce transcriptional activity could therefore impair reverse cholesterol transport at the arterial wall specifically, contributing to plaque growth and instability. The nearby promoter variant rs57137919 has been confirmed by luciferase assay to alter ABCG1 promoter activity; rs1378577 is part of the same upstream regulatory haplotype and is in linkage disequilibrium with the promoter region variants studied in Chinese Han populations.

The Evidence

The primary study of rs1378577 is Li et al. 2015 (Journal of Stroke and Cerebrovascular Diseases)³³ Li et al. 2015 (Journal of Stroke and Cerebrovascular Diseases), a case-control study of 389 ischemic stroke patients and 380 healthy controls in a Chinese Han population. In the overall cohort, no significant association was detected — but when stroke was subtyped, the G allele and TG+GG genotypes of rs1378577 were specifically associated with reduced risk of atherothrombotic stroke, the subtype driven by large-artery plaque rupture rather than cardioembolic or lacunar mechanisms. The association was particularly pronounced in the hypertriglyceridemic subgroup (144 cases, 115 controls), where the GG genotype was markedly less frequent among stroke patients, suggesting the G allele's protection is most evident when metabolic stress on macrophage lipid handling is highest.

Yang et al. 2022 (Gene)⁴⁴ Yang et al. 2022 (Gene) studied 10 ABCA1/G1 SNPs in 249 ischemic stroke patients and 226 controls, confirming that ABCG1 variants are associated with plasma lipid differences and stroke susceptibility in this population. The studies are consistent in pointing to ABCG1's role in HDL-mediated cholesterol transport as the biological substrate linking genotype to stroke risk.

Wang et al. 2020 (Annals of Vascular Surgery)⁵⁵ Wang et al. 2020 (Annals of Vascular Surgery) provided functional context by showing that ABCG1 promoter polymorphisms are associated with plasma HDL-C and LDL-C differences in Chinese Han individuals, consistent with the transporter's known role in systemic lipoprotein metabolism.

Important limitation: all published studies are from Chinese Han populations. Effect size estimates may differ in European, African, or South Asian ancestry groups. The G allele is notably more common in African populations (~50%) than European (~23%), which may reflect population-specific selection pressures and could affect how absolute risk differences translate across ancestries. Mechanistic evidence for ABCG1's role in macrophage cholesterol efflux and atherosclerosis is well-established across populations; the variant-level association requires replication in non-Asian cohorts.

Evidence level is moderate: replicated in multiple Chinese Han studies with a biologically plausible mechanism, but replication in diverse non-Asian populations is incomplete, and exact odds ratios from the abstract-available data are limited.

Practical Actions

For individuals carrying the T/T genotype (most common, ~58% globally): HDL-mediated cholesterol clearance from macrophages operates at baseline levels without the G-allele influence. Supporting ABCG1-dependent reverse cholesterol transport through specific dietary strategies — particularly increasing HDL particle function and reducing LDL oxidation exposure at arterial walls — is the most directly relevant action for this genotype.

For G/T heterozygotes: partial G-allele benefit may improve macrophage cholesterol efflux capacity and lipid profiles to an intermediate degree. Monitoring lipids and tracking HDL-C trends confirms whether the expected benefit is expressed.

For GG homozygotes: the G allele's protective association with atherothrombotic stroke is most pronounced in this genotype. This is particularly relevant in the context of elevated triglycerides, where ABCG1-dependent efflux faces the greatest metabolic challenge.

Interactions

rs1378577 is part of the same genomic region as rs57137919, an ABCG1 promoter variant associated with HDL-C, LDL-C, and CAD/stroke risk. Both variants are in linkage disequilibrium in Chinese Han populations, and their effects on ABCG1 expression are likely partially overlapping. Users carrying G alleles at both loci may experience compounded ABCG1 expression effects in macrophages.

ABCG1 works sequentially with ABCA1 in macrophage cholesterol efflux — ABCA1 (rs4149338) creates nascent HDL particles, ABCG1 (rs1378577) then loads cholesterol onto those particles. The Li et al. 2015 study examined both genes: ABCA1 variants showed opposing risk directions compared to ABCG1 variants, highlighting that dysfunction at either step in the efflux cascade can impair reverse cholesterol transport. The two-gene combination is a candidate for compound interaction analysis.